Ms. Ana Paula Celidônio
Lobo de Rizzo - Advogados
Av. Brigadeiro Faria Lima, 3900, 12º andar
Itaim Bibi
São Paulo, SP-
04538-132
Brazil
Ana Paula Santos Celidonio
Ana Paula is a Partner and the Head of Intellectual Property in the full service law firm Lobo de Rizzo, which has offices in Sao Paulo and Rio de Janeiro. She has vast experience in advising national and foreign companies in technological development, protection and consulting services related to intellectual property. She graduated in Biology from Universidade de São Paulo (USP), 1991; in Law from FADISP, 2007; specialized in Administration at Fundação Getulio Vargas (FGV-SP), 2001; and from Harvard School of Law, 2012; and in Intellectual Property from Franklin Pierce Law Center, USA, 2006.
- Member of FICPI’s Communication Committee
- Coordinator of Industrial Design Committee of the Brazilian Intellectual Property Association (ABPI)
- Member of AIPPI’s PCT Committee
- Biology Degree from “Universidade de São Paulo - Instituto de Biociências” (USP), São Paulo, 1991
- Specialized in Business Administration at the Business Administration School of São Paulo, of “Fundação Getúlio Vargas” (EAESP/FGV), São Paulo, 2001
- Specialized in Intellectual Property at the Franklin Pierce Law Center, EUA, 2006
- Graduated in Law at “Faculdade Autônoma de Direito” (FADISP), São Paulo, 2007
- Graduate in Administration for Law Firms from Harvard School of Law, 2012
Experience & Qualifications
- Biochemistry and pharmacology
- Biology; agricultural science
- Biotechnology; plant technology
- Chemistry
- Industrial chemistry and chemical engineering
- Industrial designs and copyright counselling
- Patent drafting
- Patent oppositions
- Patent prosecution
- Registered design prosecution
Roles in FICPI
-
CET 5 Biotechnology and Pharmaceuticals
CET Group 5 is dedicated to following, reporting and providing substantive comments and opinions on emerging issues relating to the patenting and regulatory affairs in the Biotechnology and Pharmaceutical fields.
In addition, CET 5 is closely following developments related to genetic resources and developing requirements for notice on their country of origin. Prominent issues CET 5 addresses regarding patenting in these technological fields include subject matter eligibility, and in particular, the patentability of chemical/biological inventions developed using machines, computer implementation and/or artificial intelligence. CET 5 supports FICPI in its mission to be an international leader promoting patent protection in the biotechnology and pharmaceutical arts.
- Member
Communications Committee
- Appointed Member
- Portuguese
- English